MICROBIAL LIGAND RECOGNITION BY INNATE IMMUNE SENSORS
先天免疫传感器识别微生物配体
基本信息
- 批准号:7957282
- 负责人:
- 金额:$ 1.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAgonistCell NucleusCell WallCharacteristicsCommunicable DiseasesComplexComputer Retrieval of Information on Scientific Projects DatabaseCrystallographyDNAEngineeringFilamentFlagellinFundingGenerationsGrantHumanImmuneImmune responseImmune systemImmunityInstitutionInvadedLigand BindingLigandsLightMeasuresMolecularMutationPatternProductionRNARecruitment ActivityResearchResearch PersonnelResourcesSignal TransductionSourceStructureSynchrotronsTLR5 geneTLR8 geneTestingTherapeuticToll-like receptorsTranslatingUnited States National Institutes of HealthVaccine AdjuvantWorkX-Ray Crystallographyantimicrobialbasecytokinedefense responsedesigninsightmicrobialmilligramnovel vaccinespathogenpreventreceptor functionsensorthree dimensional structureviral DNA
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Background
We rely on our innate immune system as the first line of defense response against invading pathogens. This immune response is critically dependent on the Toll-like receptors (TLRs). Each TLR recognizes a different molecular pattern that is characteristic of specific pathogens, such as bacterial cell wall components, bacterial filaments, or viral DNA and RNA. Upon ligand binding, TLRs transmit a signal to the nucleus that leads to the production of proinflammatory compounds. These include antimicrobial cytokines, and compounds that recruit the adaptive immune system, which establishes long-term immunity to specific pathogens.
Objectives
We will determine three-dimensional structures of human TLR5, TLR8 or TLR9, in complex with their ligands¿¿" bacterial flagellin, single-stranded RNA or CpG DNA, respectively. The structures of these complexes will provide critical insight into the molecular basis of pathogen recognition and proinflammatory signal generation.
We will express the ectodomains of TLR5/8/9 in milligram quantities and crystallize them in complex with their respective ligands. We will determine three-dimensional structures of the complexes by X-ray crystallography. To test our structure-based hypotheses on TLR function, we will measure the effect on immune signaling of engineered mutations that are predicted from the structures to interfere with ligand binding or signal generation. We propose a strategy to seek high-affinity TLR ligands, or agonists.
Relevance
Our work will reveal the molecular basis for how pathogen recognition is translated into an immune response signal. Our structures will guide efforts to design synthetic TLR agonists, which could serve as novel vaccine adjuvants, or as immunomodulatory therapeutics. Such therapeutics would provide a powerful new means to prevent and treat infectious diseases.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
背景
我们依靠先天免疫系统作为抵御入侵病原体的第一道防线。这种免疫反应严重依赖Toll样受体(TLRs)。每个TLR识别特定病原体特有的不同分子模式,如细菌细胞壁成分、细菌细丝或病毒DNA和RNA。在配体结合时,TLRs向细胞核传递信号,导致致炎化合物的产生。其中包括抗微生物细胞因子,以及招募适应性免疫系统的化合物,后者建立对特定病原体的长期免疫力。
目标
我们将分别确定人类TLR5、TLR8或TLR9与其配体细菌鞭毛蛋白、单链RNA或CpG DNA的复合体的三维结构。这些复合体的结构将为病原体识别和促炎信号的产生提供关键的分子基础。
我们将以毫克量表达TLR5/8/9的胞外结构域,并将它们与各自的配体形成络合物。我们将通过X射线结晶学来确定这些配合物的三维结构。为了测试我们关于TLR功能的基于结构的假设,我们将测量从结构预测的干扰配体结合或信号生成的工程突变对免疫信号的影响。我们提出了一种寻找高亲和力TLR配体或激动剂的策略。
相关性
我们的工作将揭示病原体识别如何转化为免疫反应信号的分子基础。我们的结构将指导设计合成TLR激动剂的努力,这些激动剂可以用作新型疫苗佐剂,或作为免疫调节疗法。这种疗法将为预防和治疗传染病提供一种强有力的新手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yorgo Modis其他文献
Yorgo Modis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yorgo Modis', 18)}}的其他基金
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
- 批准号:
8899594 - 财政年份:2012
- 资助金额:
$ 1.79万 - 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
- 批准号:
8518408 - 财政年份:2012
- 资助金额:
$ 1.79万 - 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
- 批准号:
8978926 - 财政年份:2012
- 资助金额:
$ 1.79万 - 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
- 批准号:
8345738 - 财政年份:2012
- 资助金额:
$ 1.79万 - 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
- 批准号:
8704350 - 财政年份:2012
- 资助金额:
$ 1.79万 - 项目类别:
SOLUTION STRUCTURE STUDIES OF MDA5 AND OTHER RIG-I LIKE RECEPTORS
MDA5 和其他 RIG-I 样受体的溶液结构研究
- 批准号:
8363548 - 财政年份:2011
- 资助金额:
$ 1.79万 - 项目类别:
STRUCTURAL BASIS OF INNATE IMMUNE RECOGNITION OF TOXOPLASMA GONDII
弓形虫先天免疫识别的结构基础
- 批准号:
8361693 - 财政年份:2011
- 资助金额:
$ 1.79万 - 项目类别:
MICROBIAL LIGAND RECOGNITION BY INNATE IMMUNE SENSORS
先天免疫传感器识别微生物配体
- 批准号:
8170596 - 财政年份:2010
- 资助金额:
$ 1.79万 - 项目类别:
MICROBIAL LIGAND RECOGNITION BY INNATE IMMUNE SENSORS
先天免疫传感器识别微生物配体
- 批准号:
7955157 - 财政年份:2009
- 资助金额:
$ 1.79万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 1.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




